Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $943.1 billion, total revenue of $177.12 billion and a weighted average PE ratio of 48.51.
Market Cap
943.1B
Revenue
177.12B
Profits
19.44B
PE Ratio
48.51
Profit Margin
10.98%
Dividend Yield
0.18%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 265.92B | -0.07% | 1,810,376 | 47.35B |
| 2 | DHR | Danaher Corporation | 165.55B | -0.34% | 3,208,122 | 25.61B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 55.35B | 0.85% | 422,796 | 4.66B |
| 4 | A | Agilent Technologies, Inc. | 49.89B | -0.52% | 1,890,615 | 7.37B |
| 5 | NTRA | Natera, Inc. | 46.38B | 2.51% | 1,746,103 | 2.91B |
| 6 | WAT | Waters Corporation | 46.27B | -0.97% | 651,757 | 5.61B |
| 7 | IQV | IQVIA Holdings Inc. | 45.24B | -0.23% | 1,361,261 | 17.31B |
| 8 | MTD | Mettler-Toledo International Inc. | 34.79B | -0.14% | 100,611 | 4.20B |
| 9 | ILMN | Illumina, Inc. | 32.20B | -0.92% | 1,864,942 | 4.54B |
| 10 | LH | Labcorp Holdings Inc. | 30.23B | 0.36% | 635,648 | 14.59B |
| 11 | DGX | Quest Diagnostics Incorporated | 28.46B | 0.10% | 746,382 | 11.84B |
| 12 | GH | Guardant Health, Inc. | 20.94B | -0.37% | 1,519,226 | 1.28B |
| 13 | MEDP | Medpace Holdings, Inc. | 18.59B | 0.03% | 134,529 | 2.84B |
| 14 | RVTY | Revvity, Inc. | 17.67B | -0.53% | 1,173,385 | 2.94B |
| 15 | CRL | Charles River Laboratories International, Inc. | 16.42B | -0.90% | 836,050 | 3.98B |
| 16 | ICLR | ICON Public Limited Company | 14.96B | -2.41% | 647,162 | 8.23B |
| 17 | QGEN | Qiagen N.V. | 10.39B | -0.42% | 2,372,344 | 2.12B |
| 18 | RDNT | RadNet, Inc. | 6.15B | 0.18% | 732,294 | 2.38B |
| 19 | GRAL | GRAIL, Inc. | 5.65B | 0.72% | 494,423 | 166.60M |
| 20 | BLLN | BillionToOne, Inc. | 5.27B | -1.58% | 837,012 | 436.87M |
| 21 | ADPT | Adaptive Biotechnologies Corporation | 4.85B | 1.98% | 2,629,499 | 298.01M |
| 22 | SHC | Sotera Health Company | 4.70B | 1.04% | 2,894,675 | 1.23B |
| 23 | CDNA | CareDx, Inc. | 4.26B | 0.50% | 770,744 | 497.40M |
| 24 | NEO | NeoGenomics, Inc. | 2.18B | -0.77% | 957,230 | 787.75M |
| 25 | VCYT | Veracyte, Inc. | 2.03B | 4.36% | 3,332,668 | 581.78M |
| 26 | PSNL | Personalis, Inc. | 1.73B | 0.50% | 1,138,958 | 80.77M |
| 27 | WGS | GeneDx Holdings Corp. | 1.65B | 0.53% | 1,091,201 | 460.78M |
| 28 | OPK | OPKO Health, Inc. | 1.27B | - | 2,647,990 | 654.10M |
| 29 | FRNM | Freenome, Inc. | 1.24B | 7.34% | 1,074,795 | 217.86M |
| 30 | CSTL | Castle Biosciences, Inc. | 1.05B | -1.25% | 335,264 | 377.13M |
| 31 | FLGT | Fulgent Genetics, Inc. | 718.03M | -0.31% | 494,573 | 330.28M |
| 32 | MYGN | Myriad Genetics, Inc. | 548.67M | 0.88% | 1,376,144 | 803.60M |
| 33 | BNR | Burning Rock Biotech Limited | 139.63M | 4.50% | 11,583 | 73.70M |
| 34 | XGN | Exagen Inc. | 121.97M | -4.28% | 1,201,287 | 72.30M |
| 35 | BDSX | Biodesix, Inc. | 112.22M | 1.00% | 560,410 | 105.21M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 78.21M | -3.24% | 183,286 | 1.67M |
| 37 | QUCY | Quantum Cyber N.V. | 52.50M | -9.53% | 461,251 | 537.08K |
| 38 | PRPO | Precipio, Inc. | 44.40M | 4.86% | 28,890 | 27.20M |
| 39 | MDXH | MDxHealth SA | 13.98M | 5.17% | 1,205,635 | 114.02M |
| 40 | NDRA | ENDRA Life Sciences Inc. | 7.15M | -0.03% | 5,511 | - |
| 41 | XWEL | XWELL, Inc. | 4.74M | 2.81% | 18,553 | 28.28M |
| 42 | ADVB | Advanced Biomed Inc. | 3.83M | 9.95% | 11,735 | 127.64K |
| 43 | BIAF | bioAffinity Technologies, Inc. | 3.11M | 1.46% | 75,770 | 5.53M |
| 44 | ISPC | iSpecimen Inc. | 1.79M | -3.81% | 95,565 | 466.30K |